Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomab plus rituximab in relapsed follicular non-Hodgkin lymphoma
ACTRN12608000554369Phase 2Active, not recruiting
- Sponsor
- Roche
- Start
- Aug 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 8
01
Overview
A Phase 2 trial of Apomab, rituximab in follicular lymphoma (FL), sponsored by Roche. Started Aug 2007; status: active, not recruiting.
02
Drugs
Apomabrituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on ACTRN12608000554369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000554369.